SG Americas Securities
PDSB icon

SG Americas Securities’s PDS Biotechnology PDSB Stock Holding History

SG Americas Securities’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,495
Closed -$52K – 3322
2023
Q4 		$52K Buy
+10,495
New +$52.2K ﹤0.01% 2912
2018
Q2 		– Sell
-805
Closed -$19K – 3494
2018
Q1 		$19K Buy
805
+255
+46% +$68.6K ﹤0.01% 3158
2017
Q4 		$103K Buy
+550
New +$111K ﹤0.01% 2844
2017
Q3 		– Sell
-1,149
Closed -$236K – 3677
2017
Q2 		$236K Buy
+1,149
New +$226K ﹤0.01% 2303

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SG Americas Securities's PDSB Position: Q1 2024 in Review

SG Americas Securities sold out of PDS Biotechnology (PDSB) in Q1 2024, closing a stake of 10,495 shares — an estimated $52K sold.

SG Americas Securities first reported a position in PDSB in Q2 2017 and held it in 4 quarters. The position peaked at $236K in Q2 2017. 72 funds tracked by Wall St. Rank hold PDSB as of Q1 2024.

  • SG Americas Securities reported no remaining PDS Biotechnology position as of Q1 2024 after selling out during the quarter.
  • SG Americas Securities sold 10,495 PDS Biotechnology shares in Q1 2024, an estimated $52K.
  • SG Americas Securities first reported a position in PDS Biotechnology in Q2 2017 and held it in 4 quarters.
  • SG Americas Securities's PDS Biotechnology position peaked at $236K in Q2 2017.
  • 72 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.